Distant metastasis risk and patterns of nasopharyngeal carcinoma in the era of IMRT: Long-term results and benefits of chemotherapy

Oncotarget

Volumn 6, Issue 27, 2015, Pages 24511-24521

  Li, An Chuan ^a,b   Xiao, Wei Wei ^a   Shen, Guan Zhu ^a   Wang, Lin ^a   Xu, An An ^a,c   Cao, Yan Qing ^a,d   Huang, Shao Min ^a   Lin, Cheng Guang ^a   Han, Fei ^a   Deng, Xiao Wu ^a   Zhao, Chong ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

^d GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Chemotherapy; Distant metastasis; Intensity modulated radiotherapy; Nasopharyngeal carcinoma

Indexed keywords

CISPLATIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; DISTANT METASTASIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; KAPLAN MEIER METHOD; LOCAL RECURRENCE FREE SURVIVAL; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PHYSICAL EXAMINATION; RISK ASSESSMENT; TREATMENT FAILURE; TUMOR VOLUME; BONE TUMOR; CHEMORADIOTHERAPY; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PATHOLOGY; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; SECONDARY; TUMOR RECURRENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CHEMORADIOTHERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TREATMENT FAILURE; YOUNG ADULT;

EID: 84943416384     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4312     Document Type: Article

References (31)

1. Yu MC and Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12:421-429.
2. Xiao WW, Huang SM, Han F, Wu SX, Lu LX, Lin CG, Deng XW, Lu TX, Cui NJ and Zhao C. Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy:long-term results of a phase 2 study. Cancer. 2011;117:1874-1883.
3. Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, Bosch W, Morrison WH, Quivey J, Thorstad W, Jones C and Ang KK. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol. 2009;27:3684-3690.
4. Sun X, Su S, Chen C, Han F, Zhao C, Xiao W, Deng X, Huang S, Lin C and Lu T. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma:an analysis of survival and treatment toxicities. Radiother Oncol. 2014;110:398-403.
5. Zhao C, Xiao W, Han F, Lu L, Wu S, Chen J, Lin C, Huang S, Deng X, Lu T and Cui N. Long-term outcome and prognostic factors of patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Chin J Radiat Oncol. 2010;19:191-196.
6. Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, Leung SF, Zee B and Chan AT. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy:the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60:1440-1450.
7. Chen JZ, Le QT, Han F, Lu LX, Huang SM, Lin CG, Deng XW, Cui NJ and Zhao C. Results of a phase 2 study examining the effects of omitting elective neck irradiation to nodal levels IV and Vb in patients with N(0-1) nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2013;85:929-934.
8. Langendijk JA, Leemans CR, Buter J, Berkhof J and Slotman BJ. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma:a meta-analysis of the published literature. J Clin Oncol. 2004;22:4604-4612.
9. Ng WT, Lee MC, Hung WM, Choi CW, Lee KC, Chan OS and Lee AW. Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2011;79:420-428.
10. Yi JL, Gao L, Huang XD, Li SY, Luo JW, Cai WM, Xiao JP and Xu GZ. Nasopharyngeal carcinoma treated by radical radiotherapy alone:Ten-year experience of a single institution. Int J Radiat Oncol Biol Phys. 2006;65:161-168.
11. Lee AW, Sze WM, Au JS, Leung SF, Leung TW, Chua DT, Zee BC, Law SC, Teo PM, Tung SY, Kwong DL and Lau WH. Treatment results for nasopharyngeal carcinoma in the modern era:the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2005;61:1107-1116.
12. Palazzi M, Guzzo M, Tomatis S, Cerrotta A, Potepan P, Quattrone P and Cantù G. Improved outcome of nasopharyngeal carcinoma treated with conventional radiotherapy. Int J Radiat Oncol Biol Phys. 2004;60:1451-1458.
13. Lu TX, Zhao C, Wu SX, Luo W, Chen Y, Xie FY, Chen M, Zeng XF, Hu WH, Cao XP, Xia YF, Liu XF and Cui NJ. [Retrospective analysis of 934 nasopharyngeal carcinoma patients treated with conventional external beam radiotherapy alone]. Chin J Oncol. 2005;27:620-622.
14. Lee AW, Poon YF, Foo W, Law SC, Cheung FK, Chan DK, Tung SY, Thaw M and Ho JH. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985:overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992;23:261-270.
15. Leibel SA, Scott CB, Mohiuddin M, Marcial VA, Coia LR, Davis LW and Fuks Z. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck:results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys. 1991;21:549-556.
16. Leon X, Quer M, Orus C, Del PVM and Lopez M. Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck. 2000;22:680-686.
17. Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu LZ, Sun Y, Lin AH, Liu MZ and Ma J. How does intensitymodulated radiotherapy versus conventional twodimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys. 2011;80:661-668.
18. Zhou GQ, Tang LL, Mao YP, Chen L, Li WF, Sun Y, Liu LZ, Li L, Lin AH and Ma J. Baseline serum lactate dehydrogenase levels for patients treated with intensitymodulated radiotherapy for nasopharyngeal carcinoma:a predictor of poor prognosis and subsequent liver metastasis. Int J Radiat Oncol Biol Phys. 2012;82:e359-e365.
19. Lin JC, Chen KY, Wang WY, Jan JS, Liang WM and Wei YH. Evaluation of cytokeratin-19 mRNA as a tumor marker in the peripheral blood of nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy. Int J Cancer. 2002;97:548-553.
20. Wang J, Shi M, Hsia Y, Luo S, Zhao L, Xu M, Xiao F, Fu X, Li J, Zhou B and Long X. Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China:a pilot study. Radiat Oncol. 2012;7:2.
21. Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL and Zelefsky MJ. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer:update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys. 2006;64:57-62.
22. Razak AR, Siu LL, Liu FF, Ito E, O'Sullivan B and Chan K. Nasopharyngeal carcinoma:the next challenges. Eur J Cancer. 2010;46:1967-1978.
23. Bensouda Y, Kaikani W, Ahbeddou N, Rahhali R, Jabri M, Mrabti H, Boussen H and Errihani H. Treatment for metastatic nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128:79-85.
24. National Comprehensive Cancer Network. NCCN Clinical PracticeGuidelines in Oncology:Head And Neck Cancers Version 2.2014.
25. Chan ATC, Gregoire V, Lefebvre JL, Licitra L, Hui EP, Leung SF and Felip E. Nasopharyngeal cancer:EHNSESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23:i83-i85.
26. Dou H, Hu D, Lam C, Liu Y, Wang X and Zhang W. Retrospective analysis of results of treatment for nasopharyngeal carcinoma in Macao. Chin J Cancer Res. 2014;26:148-158.
27. Tham IW, Lin S, Pan J, Han L, Lu JJ and Wee J. Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer. Am J Clin Oncol. 2010;33:294-299.
28. Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT, Kwong DL, Al-Sarraf M, Chi KH, Hareyama M, Leung SF, Thephamongkhol K and Pignon JP. Chemotherapy in locally advanced nasopharyngeal carcinoma:an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys. 2006;64:47-56.
29. Lin S, Lu JJ, Han L, Chen Q and Pan J. Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma:experience of 370 consecutive cases. Bmc Cancer. 2010;10:39.
30. Lee AW, Lau WH, Tung SY, Chua D, Chappell R, Siu L, Lau J, Law S and Xu L. Prospective randomized study on therapeutic gain achieved by addition of chemotherapy for T1-4N2-3M0 Nasopharyngeal Carcinoma (NPC). J Clin Oncol. 2004;22S:489S.
31. Lee AW, Ngan RK, Tung SY, Cheng A, Kwong DL, Lu TX, Chan AT, Chan LL, Yiu H, Ng WT, Wong F, Yuen KT, Yau S et al. Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma. Cancer. 2015;121:1328-1338.